首页> 外文期刊>Gastroenterologie clinique et biologique >Expected increase in prevalence of HCV-related cirrhosis and its complications in the United States: no effect of current antiviral treatment coverage?
【24h】

Expected increase in prevalence of HCV-related cirrhosis and its complications in the United States: no effect of current antiviral treatment coverage?

机译:在美国,HCV相关性肝硬化及其并发症的患病率预计会增加:当前抗病毒治疗的覆盖率没有影响吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Davis et al. projected the future prevalence of chronic hepatitis C (CHC) and its complications in the United States, using a multicohort natural history model with a tree model. First, the model predicted that in 2010 many patients have already progressed to F4, including to decompensated cirrhosis and HCC. Second, the model emphasized that cirrhosis and its complications are most common after 60 years old, regardless of when the infection occurred. Finally, the model showed that current treatment patterns will have little effect on the incidence of the complications hepatitis C.
机译:戴维斯等。通过使用树模型的多队列自然史模型,预测了美国慢性丙型肝炎(CHC)及其并发症的未来患病率。首先,该模型预测,到2010年,许多患者已经发展为F4,包括失代偿性肝硬化和HCC。其次,该模型强调肝硬化及其并发症在60岁以后最常见,无论何时发生感染。最后,该模型表明,当前的治疗方式对丙型肝炎并发症的发生率影响很小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号